Intravenous immunoglobulin (IVIg) is increasingly used for the treatment of inflammatory and autoimmune diseases. Although skin reactions to IVIg therapy are usually minor, rare, and not life-threatening, dermatologists need to recognize the nature of these adverse reactions. We describe a 33-year-old man suffering from demyelinating polyneuropathy who developed dyshidrotic eczema on the palms and flaky grayish-white scales on an erythematous base on his face after the administration of IVIg.
Keywords: dyshidrotic eczema; intravenous immunoglobulin; seborrheic dermatitis-like eczematous eruption; skin reaction.
© 2020 Wiley Periodicals LLC.